FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Moderna (NasdaqGS:MRNA) experienced a 10% share price increase, coinciding with broader market gains but slightly below the Nasdaq Composite's 5% rise. Despite the market being uplifted by strong ...

The latest trading day saw Moderna (MRNA) settling at $27.19, representing a -0.75% change from its previous close.

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

With a unique blend of modern beats & classic influences, Junior H's "A Tu Nombre" showcases his skill in delivering ...

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

The United States is already falling behind China in countless technological advancements, thanks to several Biden-era policies.